Modeling using discrete event simulation: A report of the ISPOR-SMDM modeling good research practices task force-4

Medical Decision Making

Volumn 32, Issue 5, 2012, Pages 701-711

  Karnon, Jonathan ^a   Stahl, James ^b   Brennan, Alan ^c   Caro, J Jaime ^d   Mar, Javier ^e   Möller, Jörgen ^f  

^a UNIVERSITY OF ADELAIDE   (Australia)

^b HARVARD MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF SHEFFIELD   (United Kingdom)

^d MCGILL UNIVERSITY   (Canada)

^e Hospital Alto Deba   (Spain)

^f UNITED BIOSOURCE CORPORATION   (United States)

Author keywords

discrete event simulation; good practices; individual simulation; methods; modeling

Indexed keywords

ARTICLE; HEALTH SERVICES RESEARCH; PRACTICE GUIDELINE; THEORETICAL MODEL;

HEALTH SERVICES RESEARCH; MODELS, THEORETICAL; PRACTICE GUIDELINES AS TOPIC;

EID: 84868128259     PISSN: 0272989X     EISSN: 1552681X     Source Type: Journal    
DOI: 10.1177/0272989X12455462     Document Type: Article

References (40)

1. Caro JJ, Briggs AH, Siebert U, Kuntz KM. Modeling good research practices-overview: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force-1. Med Decis Making. 2012 ; 32 (5). 667-677
2. Roberts M, Russell LB, Paltiel AD, Chambers M, McEwan P, Krahn M. Conceptualizing a model: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force-2. Med Decis Making. 2012 ; 32 (5). 678-689
3. Siebert U, Alagoz O, Bayoumi AM, et al. State-transition modeling: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force-3. Med Decis Making. 2012 ; 32 (5). 690-700
4. Pitman R, Fisman D, Zaric GS, et al. Dynamic transmission modeling: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force Working Group-5. Med Decis Making. 2012 ; 32 (5). 712-721
5. Briggs AH, Weinstein MC, Fenwick EAL, Karnon J, Sculpher MJ, Paltiel AD. Model parameter estimation and uncertainty analysis: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force Working Group-6. Med Decis Making. 2012 ; 32 (5). 722-732
6. Eddy DM, Hollingworth W, Caro JJ, Tsevat J, McDonald KM, Wong JB. Model transparency and validation: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force-7. Med Decis Making. 2012 ; 32 (5). 733-743
7. Pidd M Computer Simulation in Management Science. 5 th ed.New York: John Wiley; 2004. New York: John Wiley ; 2004 :
8. Jacobson SH, Hall SN, Swisher JR. Discrete-event simulation of health care systems, patient flow: reducing delay in healthcare delivery. Int Series Oper Res Manage Sci. 2006 ; 91: 211-52
9. Figge MT. Stochastic discrete event simulation of germinal center reactions. Phys Rev E Stat Nonlin Soft Matter Phys. 2005 ; 71: 1-9
10. Zand MS, Briggs BJ, Bose A, Vo T. Discrete event modeling of CD4+ memory T cell generation. J Immunol. 2004 ; 173: 3763-72
11. Coelli FC, Ferreira RB, Almeida RM, Pereira WC. Computer simulation and discrete-event models in the analysis of a mammography clinic patient flow. Comput Methods Programs Biomed. 2007 ; 87: 201-7
12. Comas M, Castells X, Hoffmeister L, et al. Discrete-event simulation applied to the analysis of waiting lists: evaluation of a prioritization system for cataract surgery. Value Health. 2008 ; 11: 1203-13
13. Stahl JE, Rattner D, Wiklund R, Lester J, Beinfeld M, Gazelle GS. Reorganizing the system of care surrounding laparoscopic surgery: a cost-effectiveness analysis using discrete-event simulation. Med Decis Making. 2004 ; 24: 461-71
14. Clark DE, Hahn DR, Hall RW, Quaker RE. Optimal location for a helicopter in a rural trauma system: prediction using discrete-event computer simulation. Proc Annu Symp Comput Appl Med Care. 1994: 888-92
15. Chase D, Roderick P, Cooper K, Davies R, Quinn T, Raftery J. Using simulation to estimate the cost effectiveness of improving ambulance and thrombolysis response times after myocardial infarction. Emerg Med J. 2006 ; 23: 67-72
16. Skolnik JM, Barrett JS, Jayaraman B, Patel D, Adamson PC. Shortening the timeline of pediatric phase I trials: the rolling six design. J Clin Oncol. 2008 ; 26: 190-5
17. Barth-Jones DC, Adams AL, Koopman JS. Monte Carlo simulation experiments for analysis of HIV vaccine effects and vaccine trial design. Winter Simulation Conference Proc ; 2000;2:198594
18. Groothuis S, van Merode GG. Discrete event simulation in the health policy and management program. Methods Inf Med. 2000 ; 39: 339-42
19. Mar J, Arrospide A, Comas M. Budget impact analysis of thrombolysis for stroke in Spain: a discrete event simulation model. Value Health. 2010 ; 13: 69-76
20. Stahl JE, Vacanti JP, Gazelle S. Assessing emerging technologies- the case of organ replacement technologies: volume, durability, cost. Int J Technol Assess Health Care. 2007 ; 23: 331-6
21. Brennan A, Chick SE, Davies R. A taxonomy of model structures for economic evaluation of health technologies. Health Econ. 2006 ; 15: 1295-310
22. Stahl JE. Modelling methods for pharmacoeconomics and health technology assessment: an overview and guide. Pharmacoeconomics. 2008 ; 26: 131-48
23. Karnon J, Brown J. Selecting a decision model for economic evaluation: a case study and review. Health Care Manage Sci. 1998 ; 1: 133-40
24. Karnon J, Czoski MC, Smith KJ, Brand C. A hybrid cohort individual sampling natural history model of age-related macular degeneration: assessing the cost-effectiveness of screening using probabilistic calibration. Med Decis Making. 2009 ; 29: 304-16
25. Tosh JC, Wailoo AJ, Scott DL, Deighton CM. Cost-effectiveness of combination nonbiologic disease-modifying antirheumatic drug strategies in patients with early rheumatoid arthritis. J Rheumatol. 2011 ; 38: 1593-600
26. Caro JJ, Ward A, Deniz HB, O'Brien JA, Ehreth JL. Cost-benefit analysis of preventing sudden cardiac deaths with an implantable cardioverter defibrillator versus amiodarone. Value Health. 2007 ; 10: 13-22
27. Jahn B, Pfeiffer KP, Theurl E, Tarride JE, Goeree R. Capacity constraints and cost-effectiveness: a discrete event simulation for drug-eluting stents. Med Decis Making. 2010 ; 30: 16-28
28. Cooper K, Davies R, Roderick P, Chase D, Raftery J. The development of a simulation model of the treatment of coronary heart disease. Health Care Manage Sci. 2002 ; 5: 259-67
29. Auchincloss AH, Diez Roux AV. A new tool for epidemiology: the usefulness of dynamic-agent models in understanding place effects on health. Am J Epidemiol. 2008 ; 168: 1-8
30. Borshchev A, Filippo VA. From system dynamics and discrete event to practical agent based modeling: reasons, techniques, tools. Presented at the 22nd International Conference of the System Dynamics Society ; Oxford, UK ;. 25-29.
31. Crane G, Karnon J, Kymes S, Metcalfe A, Casson R, Hiller J. A discrete event simulation to optimise the allocation of constrained hospital resources for glaucoma. Value Health. 2011 ; 14: A55
32. Vanni T, Karnon J, Madan J, et al. Calibrating models in economic evaluation: a seven-step approach. Pharmacoeconomics. 2011 ; 29: 35-49
33. Karnon J, Vanni T. Calibrating models in economic evaluation: a comparison of alternative measures of goodness-of-fit, parameter search strategies, and convergence criteria. Pharmacoeconomics. 2011 ; 29: 51-62
34. O'Hagan A, Buck CE, Daneshkhah A, et al Uncertain Judgements: Eliciting Expert Probabilities. Chichester, UK: Wiley ; 2006 :
35. Grimshaw JM, Thomas RE, MacLennan G, et al. Effectiveness and efficiency of guideline dissemination and implementation strategies. Health Technol Assess. 2004 ; 8: 1-72
36. Barton P, Jobanputra P, Wilson J, Bryan S, Burls A. The use of modelling to evaluate new drugs for patients with a chronic condition: the case of antibodies against tumour necrosis factor in rheumatoid arthritis. Health Technol Assess. 2004 ; 8: 1-104
37. Law AM, Kelton WD Simulation Modeling and Analysis. 4 th ed.New York: McGraw-Hill; 2007. New York: McGraw-Hill ; 2007 :
38. Duintjer Tebbens RJ, Thompson KM, Hunink MG, et al. Uncertainty and sensitivity analyses of a dynamic economic evaluation model for vaccination programs. Med Decis Making. 2008 ; 28: 182-200
39. O'Hagan A, Stevenson M, Madan J. Monte Carlo probabilistic sensitivity analysis for patient level simulation models: efficient estimation of mean and variance using ANOVA. Health Econ. 2007 ; 16: 1009-23
40. Stevenson MD, Oakley J, Chilcott JB. Gaussian process modelling in conjunction with individual patient simulation modelling: a case study describing the calculation of cost-effectiveness ratios for the treatment of osteoporosis. Med Decis Making. 2004 ; 24: 89-100